Taking Out OGA. The rationale behind small-molecule OGA inhibition is that these drugs will decrease tau hyperphosphorylation and aggregation into neurofibrillary tangles (right). [Courtesy of Eli ...
Clinical Assessment Is Being Performed on a Pediatric Patient at Children’s Health Ireland in Dublin Second Clinical Site to Open in Spain with Potentially Three Additional Pediatric Netherton ...